Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  RaySearch Laboratories AB (publ)    RAY B   SE0000135485

RAYSEARCH LABORATORIES AB (PUBL)

(RAY B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

RaySearch Laboratories publ : Axim Nuclear & Oncology to supply RaySearch systems to South African radiotherapy market

share with twitter share with LinkedIn share with facebook
06/24/2020 | 10:46am EDT

RaySearch Laboratories AB (publ) shares news that Axim Nuclear & Oncology will be supplying treatment planning system RayStation®* to the radiotherapy market in South Africa.

Axim Nuclear & Oncology specializes in the sales and applications of nuclear medicine and radiation oncology products. The company currently supplies linear accelerators from Accuray, surface guided radiation therapy equipment from Vision RT, laser positioning equipment from LAP, medical physics QA from the Sun Nuclear Corporation and brachytherapy solutions from Xoft, a subsidiary of iCAD, Inc.

[image]The South African market for treatment planning software is roughly split into privately-owned oncology practices as well as government-run oncology centers. The installed linear accelerator (LINAC) base of more than 80 linear accelerators are predominantly from Elekta and Varian.

Johan Löf, founder and CEO, RaySearch, says: "As with any market expansion, reaching the South African market with our advanced treatment planning system RayStation is a milestone and a cause for optimism. Together with new distributor agreements in North Africa and South America, RaySearch software is becoming available to many more medical professionals each year."
 

For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

Peter Thysell, CFO, RaySearch Laboratories AB (publ) 
Telephone: +46 (0)70 661 05 59
peter.thysell@raysearchlabs.com
 

About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide. 

 

* Subject to regulatory clearance in some markets.

More information about RaySearch is available at www.raysearchlabs.com

https://news.cision.com/raysearch-laboratories/r/axim-nuclear---oncology-to-supply-raysearch-systems-to-south-african-radiotherapy-market,c3141170

https://mb.cision.com/Main/1102/3141170/1269190.pdf

https://news.cision.com/raysearch-laboratories/i/axim-nuclear-and-oncology-without-reg-no,c2799894

(c) 2020 Cision. All rights reserved., source Press Releases - English


Stocks mentioned in the article
ChangeLast1st jan.
ICAD, INC. -3.65% 9.78 Delayed Quote.25.87%
RAYSEARCH LABORATORIES AB (PUBL) -1.70% 75 Delayed Quote.-30.04%
share with twitter share with LinkedIn share with facebook
All news about RAYSEARCH LABORATORIES AB (PUBL)
10/23RAYSEARCH LABORATORIES : will present further advances in machine learning and s..
AQ
09/16RAYSEARCH LABORATORIES : Cutting-edge cancer treatment comes to Belgium with the..
AQ
08/28RAYSEARCH LABORATORIES : RayStation in clinical use at both of Spain's proton ce..
AQ
08/26RAYSEARCH LABORATORIES : Interim report January 1 - June 30, 2020
AQ
07/15RAYSEARCH LABORATORIES PUBL : and TAE Life Sciences announce agreement on RaySta..
AQ
07/09RAYSEARCH LABORATORIES PUBL : Further clinical implementation of deep learning s..
AQ
06/30RAYSEARCH LABORATORIES PUBL : Bulletin from the Annual General Meeting 2020
AQ
06/29RAYSEARCH LABORATORIES PUBL : Machine learning algorithm from RaySearch enhances..
AQ
06/29RAYSEARCH LABORATORIES PUBL : Pioneering oncology information system RayCare 4A ..
AQ
06/24RAYSEARCH LABORATORIES PUBL : Axim Nuclear & Oncology to supply RaySearch system..
AQ
More news
Financials
Sales 2020 779 M 88,0 M 88,0 M
Net income 2020 66,5 M 7,52 M 7,52 M
Net cash 2020 15,0 M 1,70 M 1,70 M
P/E ratio 2020 38,9x
Yield 2020 0,40%
Capitalization 2 571 M 291 M 291 M
EV / Sales 2020 3,28x
EV / Sales 2021 2,79x
Nbr of Employees 396
Free-Float 69,7%
Chart RAYSEARCH LABORATORIES AB (PUBL)
Duration : Period :
RaySearch Laboratories AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RAYSEARCH LABORATORIES AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 93,50 SEK
Last Close Price 75,00 SEK
Spread / Highest target 26,7%
Spread / Average Target 24,7%
Spread / Lowest Target 22,7%
EPS Revisions
Managers
NameTitle
Johan Löf President, Chief Executive Officer & Director
Lars Micael Wollung Chairman
Peter Thysell Chief Financial Officer
Kjell Eriksson Chief Research Officer
Carl Filip Bergendal Director
Sector and Competitors
1st jan.Capitalization (M$)
RAYSEARCH LABORATORIES AB (PUBL)-30.04%301
VEEVA SYSTEMS INC.107.71%45 602
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED133.33%36 424
OMNICELL, INC.6.83%3 660
SECTRA AB (PUBL)44.63%2 505
B-SOFT CO.,LTD.15.64%2 442